Literature DB >> 9688593

Effects of local anesthetics on Na+ channels containing the equine hyperkalemic periodic paralysis mutation.

R L Sah1, R G Tsushima, P H Backx.   

Abstract

We examined the ability of local anesthetics to correct altered inactivation properties of rat skeletal muscle Na+ channels containing the equine hyperkalemic periodic paralysis (eqHPP) mutation when expressed in Xenopus oocytes. Increased time constants of current decay in eqHPP channels compared with wild-type channels were restored by 1 mM benzocaine but were not altered by lidocaine or mexiletine. Inactivation curves, which were determined by measuring the dependence of the relative peak current amplitude after depolarization to -10 mV on conditioning prepulse voltages, could be shifted in eqHPP channels back toward that observed for wild-type (WT) channels using selected concentrations of benzocaine, lidocaine, and mexiletine. Recovery from inactivation at -80 mV (50-ms conditioning pulse) in eqHPP channels followed a monoexponential time course and was markedly accelerated compared with wild-type channels (tauWT = 10.8 +/- 0.9 ms; taueqHPP = 2.9 +/- 0.4 ms). Benzocaine slowed the time course of recovery (taueqHPP,ben = 9.6 +/- 0.4 ms at 1 mM) in a concentration-dependent manner. In contrast, the recovery from inactivation with lidocaine and mexiletine had a fast component (taufast,lid = 3.2 +/- 0.2 ms; taufast,mex = 3.1 +/- 0.2 ms), which was identical to the recovery in eqHPP channels without drug, and a slow component (tauslow,lid = 1,688 +/- 180 ms; tauslow,mex = 2,323 +/- 328 ms). The time constant of the slow component of the recovery from inactivation was independent of the drug concentration, whereas the fraction of current recovering slowly depended on drug concentrations and conditioning pulse durations. Our results show that local anesthetics are generally incapable of fully restoring normal WT behavior in inactivation-deficient eqHPP channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688593     DOI: 10.1152/ajpcell.1998.275.2.C389

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Voltage-dependent blockade of normal and mutant muscle sodium channels by benzylalcohol.

Authors:  G Haeseler; M Mamarvar; J Bufler; R Dengler; H Hecker; J K Aronson; S Piepenbrock; M Leuwer
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Voltage-dependent block of normal and mutant muscle sodium channels by 4-Chloro-m-Cresol.

Authors:  G Haeseler; M Leuwer; J Kavan; A Würz; R Dengler; S Piepenbrock
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.

Authors:  M P Takahashi; S C Cannon
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

Review 4.  Channelopathies: ion channel defects linked to heritable clinical disorders.

Authors:  R Felix
Journal:  J Med Genet       Date:  2000-10       Impact factor: 6.318

5.  Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.

Authors:  J F Desaphy; D Conte Camerino; C Franchini; G Lentini; V Tortorella; A De Luca
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.